| Heartland Group Holdings Limited (HGH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$733 |
Heartland announces FY2025 result and outlook for FY2026
|
21 Aug 2025 7:30AM |
$0.740 |
$0.780 |
risen by
5.41%
|
|
HGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Heartland Group Holdings Limited reported FY2024 NPAT of $82.0 million, down from the prior year due to higher funding costs and competitive lending.
- Core business segments such as reverse mortgages and livestock finance experienced growth.
- Focus areas remain on digital transformation, operational efficiency, and prudent capital management.
- FY2025 outlook includes forecasted NPAT of $88 million to $93 million, subject to market conditions.
- Continued investment in digital platforms is expected to drive customer experience improvements and operational scalability.
- Company remains committed to disciplined cost management and growth in selected segments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$20,355 |
FPH provides first half guidance for FY26
|
21 Aug 2025 7:30AM |
$34.270 |
$34.720 |
risen by
1.31%
|
|
FPH - Price-sensitive ASX Announcement
Full Release
Key Points
- FPH reported operating revenue of $1.75 billion for the year ended 31 March 2024, a 10% increase.
- Net profit after tax for the year was $209.3 million, up 17%.
- Hospital product group revenue increased 12% to $1.0 billion.
- Homecare product group revenue grew 7% to $737.6 million.
- A final dividend of 23.0 cents per share will be paid on 10 July 2024.
- Guidance for the first half of FY25 is operating revenue of ~$910 million and net profit after tax of $95m–$105m.
- Revenue growth attributed to higher demand for respiratory care and surgical products.
- Ongoing investment in research and development to support product innovation.
- FPH continues to expand its global reach and remains vigilant amid healthcare sector uncertainties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mercury NZ Limited (MCY) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$8,386 |
Notice of Annual Shareholders Meeting
|
21 Aug 2025 7:30AM |
$5.970 |
$5.960 |
fallen by
0.17%
|
|
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$359 |
Synlait FY25 results date and conference call details
|
21 Aug 2025 7:30AM |
$0.600 |
$0.595 |
fallen by
0.83%
|
|
| Auckland International Airport Limited (AIA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$11,817 |
Dividend/Distribution - AIA
|
21 Aug 2025 7:30AM |
$7.090 |
$7.000 |
fallen by
1.27%
|
|
| TURNERS AUTOMOTIVE GROUP LIMITED (TRA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$466 |
Turners 2025 Annual Meeting Presentation
|
21 Aug 2025 7:30AM |
$5.150 |
$5.150 |
fallen by
0%
|
|
TRA - Price-sensitive ASX Announcement
Full Release
Key Points
- Record trading profit and 11th consecutive year of profit growth in FY24.
- Strong performance across all business segments, with automotive retail, finance, and insurance all contributing.
- Expansion of branch network and increased vehicle processing capacity.
- Strategic priorities include network growth, brand awareness, digital enablement, and operational efficiency.
- Continued focus on core automotive lending with disciplined credit risk management.
- Strong dividend policy with high payout ratio and commitment to shareholder returns.
- Ongoing investment in digital platforms, marketing, and employee development.
- Resilience to economic challenges and successful navigation of inflation and interest rate headwinds.
- Plans for further branch expansion and digital transformation in FY25 and beyond.
- Commitment to ESG principles, including workplace safety, diversity, and community support.
- Long-term goal to deliver sustainable shareholder value through scale, efficiency, and market leadership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Auckland International Airport Limited (AIA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$11,817 |
AIA - FY25 Annual Results
|
21 Aug 2025 7:30AM |
$7.090 |
$7.000 |
fallen by
1.27%
|
|
AIA - Price-sensitive ASX Announcement
Full Release
Key Points
- AIA reports strong recovery in passenger numbers, nearing or surpassing pre-pandemic levels.
- Both aeronautical and non-aeronautical revenues experienced significant growth year-on-year.
- Major capital projects focus on terminal integration, transport upgrades, and sustainability initiatives.
- Sustainability remains a priority, with progress on emissions reduction and energy efficiency projects.
- Customer experience improvements include terminal refurbishments and expanded retail and hospitality offerings.
- AIA highlights increased operational resilience in response to evolving health and security challenges.
- Dividend and capital management policies are detailed, with positive guidance for future shareholder returns.
- Forward outlook acknowledges macroeconomic uncertainties but maintains confidence in medium- to long-term growth.
- The company engages actively with government, regulators, and stakeholders to ensure sustainable operations.
- FY25 guidance expects continued growth in passenger numbers and revenue, supported by ongoing investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$40 |
Notification regarding unquoted securities - DVL
|
20 Aug 2025 7:30PM |
$0.045 |
$0.044 |
fallen by
2.22%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$40 |
Section 708A Cleansing Notice
|
20 Aug 2025 7:30PM |
$0.045 |
$0.044 |
fallen by
2.22%
|
|
| Elsight Limited (ELS) ORDINARY FULLY PAID |
Information Technology |
$377 |
Change in substantial holding
|
20 Aug 2025 7:30PM |
$1.790 |
$1.725 |
fallen by
3.63%
|
|
| Complii Fintech Solutions Ltd (CF1) ORDINARY FULLY PAID |
Information Technology |
$12 |
Change of Directors' Interest Notices
|
20 Aug 2025 7:25PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
| Complii Fintech Solutions Ltd (CF1) ORDINARY FULLY PAID |
Information Technology |
$12 |
Notification of cessation of securities - CF1
|
20 Aug 2025 7:24PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
| Complii Fintech Solutions Ltd (CF1) ORDINARY FULLY PAID |
Information Technology |
$12 |
Annual Report to shareholders
|
20 Aug 2025 7:24PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$20 |
Notice of General Meeting/Proxy Form
|
20 Aug 2025 7:23PM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| Kaili Resources Limited (KLR) 125C ORDINARY FULLY PAID |
Energy |
$28 |
Reinstatement to Quotation
|
20 Aug 2025 7:22PM |
$1.080 |
$0.190 |
fallen by
82.41%
|
|
KLR - Price-sensitive ASX Announcement
Full Release
Key Points
- Kaili Resources Limited securities will be reinstated to quotation on the ASX effective 10:00 AM AEDT Friday, 3 November 2017.
- Reinstatement follows the company’s compliance with Chapters 1 and 2 of the ASX Listing Rules.
- Details of the capital structure are provided, including escrowed and quoted securities.
- The announcement includes the company’s completed milestones such as raising capital and compliance with regulatory requirements.
- Information about the nature of the company’s business, its board of directors, and the issued options is included.
- Escrow arrangements for certain securities are specified.
- The document serves as a formal notice from ASX and Kaili Resources Limited regarding the reinstatement process and status.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kaili Resources Limited (KLR) 125C ORDINARY FULLY PAID |
Energy |
$28 |
Response to ASX Query Letter
|
20 Aug 2025 7:21PM |
$1.080 |
$0.190 |
fallen by
82.41%
|
|
KLR - Price-sensitive ASX Announcement
Full Release
Key Points
- Kaili Resources Limited received a query letter from the ASX requesting clarification on recent disclosures and trading activity.
- The company responded with explanations concerning the timing and content of its prior announcements.
- KLR addressed questions related to compliance with ASX Listing Rules, particularly regarding continuous disclosure obligations.
- The company asserts that all material information has been disclosed to the market as required.
- KLR's response includes statements from directors confirming that the response is complete and accurate.
- The document demonstrates the company's commitment to transparency and regulatory compliance.
- All answers provided aim to satisfy the ASX's concerns and reinforce KLR's adherence to corporate governance standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Complii Fintech Solutions Ltd (CF1) ORDINARY FULLY PAID |
Information Technology |
$12 |
Appendix 4E - Preliminary Final Report
|
20 Aug 2025 7:19PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
CF1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Complii Fintech Solutions Ltd lodged its Appendix 4E Preliminary Final Report for the year ended 30 June 2023.
- The company reported a decrease in revenue compared to the previous financial year.
- Net loss after tax was recorded, attributed to ongoing investment in technology and subdued market conditions.
- There were no dividends declared or paid during the reporting period.
- Significant focus was placed on operational efficiencies and technology development.
- The company continued to expand and develop its fintech platform and product offerings.
- Details of subsidiary entities and their contributions are provided.
- No significant subsequent events or changes in control of entities were reported post-30 June 2023.
- The report includes compliance declarations, audit information, and remuneration disclosures.
- Outlook commentary emphasizes ongoing product innovation and market adaptation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Complii Fintech Solutions Ltd (CF1) ORDINARY FULLY PAID |
Information Technology |
$12 |
Corporate Governance Statement and Appendix 4G
|
20 Aug 2025 7:12PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
| Spheria Emerging Companies Limited (SEC) ORDINARY FULLY PAID |
Financials |
$159 |
Net Tangible Asset Backing
|
20 Aug 2025 7:11PM |
$2.650 |
$2.650 |
fallen by
0%
|
|
| Lifestyle Communities Limited (LIC) ORDINARY FULLY PAID |
Real Estate |
$620 |
Change in substantial holding
|
20 Aug 2025 7:11PM |
$5.090 |
$5.090 |
fallen by
0%
|
|
| The Star Entertainment Group Limited (SGR) ORDINARY FULLY PAID |
Consumer Discretionary |
$301 |
Change in substantial holding
|
20 Aug 2025 7:11PM |
$0.105 |
$0.105 |
fallen by
0%
|
|
| Arafura Rare Earths Ltd (ARU) ORDINARY FULLY PAID |
Materials |
$481 |
Ceasing to be a substantial holder
|
20 Aug 2025 7:10PM |
$0.190 |
$0.195 |
risen by
2.63%
|
|
| Centrex Limited (CXM) ORDINARY FULLY PAID |
Materials |
$15 |
PRG: Centrex Ltd (Administrators Appointed) Court Order
|
20 Aug 2025 7:09PM |
$0.017 |
$0.017 |
fallen by
0%
|
|
| PRL Global Ltd (PRG) ORDINARY FULLY PAID |
Materials |
$182 |
Centrex Ltd (Administrators Appointed) Court Order Granted
|
20 Aug 2025 7:09PM |
$1.608 |
$1.620 |
risen by
0.78%
|
|
| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$204 |
Appendix 4E and Annual Financial Statements
|
20 Aug 2025 7:06PM |
$1.300 |
$1.790 |
risen by
37.69%
|
|
AYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Artrya Limited released its Appendix 4E and Annual Financial Statements for FY2023.
- The company reported a statutory net loss for the financial year ended 30 June 2023.
- Key operational highlights include progress on the AYA platform, regulatory submissions, and international expansion.
- Revenue streams remain limited, with ongoing investment in product development and regulatory approvals.
- The financial report includes detailed analysis of income, expenses, and cash flows.
- Principal activities focus on health technology solutions for coronary artery disease, with the AYA platform central to operations.
- Research collaborations and regulatory achievements in Australia and overseas were noted.
- Corporate governance, director’s report, share structure, and risk management strategies are outlined.
- Remuneration details and future outlook are provided, with emphasis on continued R&D and commercialization efforts.
- The macroeconomic environment presents challenges, but the company remains focused on growth and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
